CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Mar. 30, 2025	Mar. 31, 2024	Mar. 30, 2025	Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		$ 1,330,667	$ 965,826	$ 3,638,129	$ 2,807,490
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization				287,838	271,342
Deferred income taxes				(211,568)	(137,606)
Equity-based compensation expense		87,115	76,854	249,085	213,966
Other, net				(7,395)	14,242
Changes in operating assets and liabilities				(337,013)	620,405
Net cash provided by operating activities				3,619,076	3,789,839
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets				(586,995)	(295,922)
Proceeds from maturities of available-for-sales securities				0	34,336
Proceeds from sales of available-for-sale securities				0	3,430
Other, net				8,154	(10,845)
Net cash used for investing activities				(578,841)	(269,001)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt, including finance lease obligations and payments for debt issuance costs				(506,003)	(255,155)
Treasury stock purchases, including excise tax payments				(2,130,044)	(2,469,257)
Dividends paid				(854,335)	(757,453)
Reissuance of treasury stock related to employee stock purchase plan				60,557	53,081
Proceeds from issuance of common stock, net issuance costs				1,756	12,757
Other, net				963	(5,672)
Net cash used for financing activities				(3,427,106)	(3,421,699)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash				(960)	(12,758)
Net change in cash, cash equivalents, and restricted cash				(387,831)	86,381
Cash, cash equivalents, and restricted cash at beginning of period	[1]			5,850,803	5,587,372
Cash, cash equivalents, and restricted cash at end of period	[1]	5,462,972	5,673,753	5,462,972	5,673,753
Schedule of non-cash transactions:
Accrued payables for stock repurchases, including applicable excise tax				16,967	36,863
Accrued payables for capital expenditures				87,291	45,122
Dividends payable		295,423	261,463	295,423	261,463
Transfers of finished goods inventory to property and equipment				74,560	55,290
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents		5,450,718	5,672,232	5,450,718	5,672,232
Restricted cash and cash equivalents	[1]	12,254	1,521	12,254	1,521
Total cash, cash equivalents, and restricted cash	[1]	$ 5,462,972	$ 5,673,753	$ 5,462,972	$ 5,673,753

[1] Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets